Italy is on the list of countries that question the COVID-19 vaccine made in China.
Italian Prime Minister Mario Draghi At the end of the European Union Summit on June 22, he told reporters: You can see it from the experience of Chile’s epidemic efforts. “
More than half of Chile’s population is vaccinated with Chinese-made Sinovac vaccine, but the efficacy rate after the first dose is Reportedly 16 percent 67% after the second dose. Chile is one of the top 10 countries most affected by COVID-19.
On June 24, Feng Zijian, a researcher and former deputy director of the Chinese Center for Disease Control and Prevention, said: Approved at the interview China’s state media CCTV states that Chinese vaccines do not produce enough antibodies and are less effective against delta variants of the virus (formerly known as Indian variants).
Delta variants have caused 85% of infections in the recent surge in COVID-19 in Guangdong, China, despite tens of millions of locals being vaccinated.
So far, the Chinese vaccine has not been approved for use by the United States and the European Union. Chinese vaccines are also excluded from the EU’s Digital Immunization Pass Program. The Chinese administration has announced retaliation measures, denied entry to unvaccinated travelers in China, and does not allow vaccinations outside of China. This measure prevented many overseas Chinese citizens from returning home.
Despite its low efficacy and lack of transparency of study data, the World Health Organization recently approved both the Sinopharm and Sinovac vaccines for emergency use.
It comes as more countries around the world are questioning Chinese vaccines.
On June 17, Indonesia’s more than 350 doctors and healthcare workers were vaccinated with Sinovac, but were infected with COVID-19, dozens of people were hospitalized, and a particularly more infectious variant of the virus. It raised serious questions about the effectiveness of the vaccine against the body. .. Indonesia has purchased a Chinese vaccine and has given it to many citizens.
The United Arab Emirates released the Sinopharm vaccine to the public in December 2020, and the third Sinopharm vaccine from March after it was discovered that the vaccine did not produce sufficient antibodies to some recipients. Is provided.
In March, Takafuku, director of the Chinese Center for Disease Control and Prevention, said a third dose of the Chinese-made COVID-19 vaccine could be needed to increase its effectiveness.
At the National Conference on Vaccines and Health in China in April, Gao said that Chinese vaccines that use inactivated viruses have low protection against infection and that they mix different types of vaccines made with different technologies. We acknowledged that it may improve effectiveness. As mRNA used in Western vaccines.
In the same month, the UAE launched the Pfizer / BioNTech vaccine as a booster to people vaccinated in China.
By early June, 47% of Bahrain’s population had been fully vaccinated and 60% had been vaccinated against China National Pharmaceutical. However, the number of confirmed cases is currently at record highs in Bahrain, and since the end of May authorities have provided Pfizer vaccine as a booster shot to people who are already fully vaccinated at China National Pharmaceutical.
In early June, a clinical study in Serbia reported that 30% of patients over the age of 65 did not have antibodies after receiving the Sinopharm vaccine. Serbia is the first European country to use a Chinese vaccine, even though it has not been approved by the European Medicines Agency.
In addition to many countries in Latin America, Africa and Asia, Hungary and Serbia in Europe are all vaccinated against China and are currently experiencing a surge in COVID-19 infections.
by Our world in data, Seychelles, Chile, Bahrain, Mongolia, etc., where about 50-68% of the population is fully vaccinated with China, is one of the top 10 countries with the lowest COVID-19 outbreaks.